Pharmaceutical company Corona Remedies Ltd posted robust financial results for the December quarter (Q3 FY26), with consolidated revenue from operations rising to ₹3.42 billion and net profit reaching ₹412.7 million. The performance reflects strong demand across therapeutic segments, operational efficiency, and continued expansion in domestic and international markets.
Show moreStay Ahead – Explore Now! Magellanic Cloud Secures ₹53.6 Million Order from Central Railway Nagpur
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
